These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Efficacy and feasibility of SMS m-Health for the detection of adverse events following immunisation (AEFIs) in resource-limited setting-The Zimbabwe stimulated telephone assisted rapid safety surveillance (Zm-STARSS) randomised control trial. Nyambayo PPM; Gold MS; Mehta UC; Clarke S; Manyevere R; Chirinda L; Zifamba EN; Nyamandi T Vaccine; 2023 Oct; 41(45):6700-6709. PubMed ID: 37805357 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of m-Health for the detection of adverse events following immunization - The stimulated telephone assisted rapid safety surveillance (STARSS) randomised control trial. Gold MS; Lincoln G; Cashman P; Braunack-Mayer A; Stocks N Vaccine; 2021 Jan; 39(2):332-342. PubMed ID: 33279317 [TBL] [Abstract][Full Text] [Related]
8. Active SMS-based surveillance of adverse events following immunisation with influenza and pertussis-containing vaccines in Australian pregnant women using AusVaxSafety. Glover C; Crawford N; Leeb A; Wood N; Macartney K Vaccine; 2020 Jun; 38(31):4892-4900. PubMed ID: 32499067 [TBL] [Abstract][Full Text] [Related]
9. Smartphone-based active vaccine safety surveillance (SmartVax) at a Swiss adult vaccination clinic - a pilot study. Guedel DS; Peters IJ; Banderet F; Epple V; Egli S; Mehling M; Mayr M; Leeb A; Berger CT Swiss Med Wkly; 2021 Dec; 151():w30090. PubMed ID: 34908642 [TBL] [Abstract][Full Text] [Related]
11. Use of a text message-based pharmacovigilance tool in Cambodia: pilot study. Baron S; Goutard F; Nguon K; Tarantola A J Med Internet Res; 2013 Apr; 15(4):e68. PubMed ID: 23591700 [TBL] [Abstract][Full Text] [Related]
12. Annual report: surveillance of adverse events following immunisation in Australia, 2009. Mahajan D; Roomiani I; Gold MS; Lawrence GL; McIntyre PB; Menzies RI Commun Dis Intell Q Rep; 2010 Sep; 34(3):259-76. PubMed ID: 21090181 [TBL] [Abstract][Full Text] [Related]
13. Consumer acceptability and validity of m-Health for the detection of adverse events following immunization - The Stimulated Telephone Assisted Rapid Safety Surveillance (STARSS) randomised control trial. Gold MS; Lincoln G; Bednarz J; Braunack-Mayer A; Stocks N Vaccine; 2021 Jan; 39(2):237-246. PubMed ID: 33309486 [TBL] [Abstract][Full Text] [Related]
14. A multi-site feasibility study to assess fever and wheezing in children after influenza vaccines using text messaging. Stockwell MS; Marchant CD; Wodi AP; Barnett ED; Broder KR; Jakob K; Lewis P; Kattan M; Rezendes AM; Barrett A; Sharma D; Fernandez N; LaRussa P Vaccine; 2017 Dec; 35(50):6941-6948. PubMed ID: 29089191 [TBL] [Abstract][Full Text] [Related]
15. Vaxtracker: Active on-line surveillance for adverse events following inactivated influenza vaccine in children. Cashman P; Moberley S; Dalton C; Stephenson J; Elvidge E; Butler M; Durrheim DN Vaccine; 2014 Sep; 32(42):5503-8. PubMed ID: 25077424 [TBL] [Abstract][Full Text] [Related]
16. Randomized Controlled Trial of Text Message Reminders for Increasing Influenza Vaccination. Regan AK; Bloomfield L; Peters I; Effler PV Ann Fam Med; 2017 Nov; 15(6):507-514. PubMed ID: 29133488 [TBL] [Abstract][Full Text] [Related]
17. Vaccines safety; effect of supervision or SMS on reporting rates of adverse events following immunization (AEFI) with meningitis vaccine (MenAfriVac™): a randomized controlled trial. Ateudjieu J; Stoll B; Nguefack-Tsague G; Tchangou C; Genton B Vaccine; 2014 Sep; 32(43):5662-8. PubMed ID: 25160064 [TBL] [Abstract][Full Text] [Related]
18. Annual report: surveillance of adverse events following immunisation in Australia, 2004. Lawrence GL; Boyd I; McIntyre PB; Isaacs D Commun Dis Intell Q Rep; 2005; 29(3):248-62. PubMed ID: 16220860 [TBL] [Abstract][Full Text] [Related]
19. Parental views on vaccine safety and future vaccinations of children who experienced an adverse event following routine or seasonal influenza vaccination in 2010. Parrella A; Gold M; Marshall H; Braunack-Mayer A; Watson M; Baghurst P Hum Vaccin Immunother; 2012 May; 8(5):662-7. PubMed ID: 22634441 [TBL] [Abstract][Full Text] [Related]
20. Annual report: Surveillance of adverse events following immunisation in Australia, 2005. Lawrence G; Boyd I; McIntyre P; Isaacs D Commun Dis Intell Q Rep; 2006; 30(3):319-33. PubMed ID: 17120485 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]